Peer Reviewed
Feature Article Genetics

Prenatal screening for Down syndrome: the past, present and future

Michel R Sangalli, David A Ellwood
Abstract
This article traces the development of prenatal screening programs for Down syndrome from maternal age to second and then first trimester screening. Future possibilities for noninvasive diagnosis are also presented.
Key Points
  • The prenatal diagnosis of Down syndrome currently requires an invasive test (either amniocentesis or chorionic villous sampling) with an inherent risk of miscarriage.
  • If invasive testing were conducted in all women of advanced maternal age, only up to 30% of cases would be detected. Further, only about one in 140 would carry an affected fetus.
  • Second trimester screening for risk of Down syndrome (serum and/or ultrasound-based) can be undertaken in pregnant women of any age.
  • First trimester screening for risk of Down syndrome (ultrasound and/or serum-based) is now available in some centres.
  • A noninvasive diagnostic test for Down syndrome using fetal cells or fetal DNA isolated from maternal blood may become available in the next decade.
Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?